These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25162148)

  • 1. Major depressive disorder and cognitive impairment.
    McIntyre RS
    J Psychiatry Neurosci; 2014 Sep; 39(5):E36-7. PubMed ID: 25162148
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding and managing Cognition in the Depressed Patient.
    Papakostas GI; Culpepper L
    J Clin Psychiatry; 2015 Apr; 76(4):418-25. PubMed ID: 25919832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On 'cognitive dysfunction' as a novel target for antidepressant treatment.
    Impey B; Baldwin DS
    Hum Psychopharmacol; 2013 Nov; 28(6):535-7. PubMed ID: 24519689
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognition as a target in major depression: new developments.
    Solé B; Jiménez E; Martinez-Aran A; Vieta E
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):231-47. PubMed ID: 25640673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Fossati P
    Rev Neurol (Paris); 2018 Apr; 174(4):212-215. PubMed ID: 29618408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrent depression: episodes neurotoxicity and recurrences prevention].
    Gorwood P
    Encephale; 2010 Dec; 36 Suppl 5():S136-9. PubMed ID: 21211634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood, psychomotor, and cognitive function in major depressive disorder: from biomarkers to rapid-acting antidepressants.
    Hashimoto K
    Eur Arch Psychiatry Clin Neurosci; 2019 Oct; 269(7):759-760. PubMed ID: 31456036
    [No Abstract]   [Full Text] [Related]  

  • 8. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Rosenblat JD; Kakar R; McIntyre RS
    Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26209859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI).
    McIntyre RS; Lee Y
    Curr Opin Psychiatry; 2016 Jan; 29(1):48-55. PubMed ID: 26575300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric symptoms in Lewy body diffuse disease: a case report.
    Salazar G; Cuello D; Fragoso M; Benlloc L
    Neurologia; 2011 Oct; 26(8):499-502. PubMed ID: 21477898
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive remission: a novel objective for the treatment of major depression?
    Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
    BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects.
    McIntyre RS; Johe K; Rong C; Lee Y
    Expert Opin Investig Drugs; 2017 Jun; 26(6):767-770. PubMed ID: 28460574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in major depressive disorder.
    Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS
    CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent depression in the elderly: what cognitive prognosis?].
    Benoit M
    Encephale; 2010 Dec; 36 Suppl 5():S132-5. PubMed ID: 21211633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment.
    Wagner S; Doering B; Helmreich I; Lieb K; Tadić A
    Acta Psychiatr Scand; 2012 Apr; 125(4):281-92. PubMed ID: 22007857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal visuospatial function and volume in remitted depressed patients: an 8-year follow-up study.
    Hviid LB; Ravnkilde B; Ahdidan J; Rosenberg R; Stødkilde-Jørgensen H; Videbech P
    J Affect Disord; 2010 Sep; 125(1-3):177-83. PubMed ID: 20219249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant drug action: a neuropsychological perspective.
    Harmer CJ
    Depress Anxiety; 2010 Mar; 27(3):231-3. PubMed ID: 20196098
    [No Abstract]   [Full Text] [Related]  

  • 18. Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder.
    Madhoo M; Keefe RS; Roth RM; Sambunaris A; Wu J; Trivedi MH; Anderson CS; Lasser R
    Neuropsychopharmacology; 2014 May; 39(6):1388-98. PubMed ID: 24309905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Do cognitive deficits in depressive disorders remit?].
    Frasch K; Bretschneider S; Bullacher C; Hess R; Wittek R; Neumann NU
    Psychiatr Prax; 2000 Sep; 27(6):291-5. PubMed ID: 11050736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring cognitive function in MDD: emerging assessment tools.
    Russo M; Mahon K; Burdick KE
    Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.